Dr. Khuri Discusses Survivorship in Lung Cancer Patients

Video

Fadlo R. Khuri, MD, FACP, professor, chair, hematology/medical oncology, Emory University School of Medicine, deputy director, Winship Cancer Institute, discusses survivorship in lung cancer.

Fadlo R. Khuri, MD, FACP, professor, chair, hematology/medical oncology, Emory University School of Medicine, deputy director, Winship Cancer Institute, discusses survivorship in lung cancer.

Khuri says one of the most exciting things that has happened in the last decade is that survivorship in lung cancer is being discussed. In the past, chemotherapy was not yet standard for advanced or metastatic disease and was purely experimental.

Now, patients are living longer and there are different treatments available to patients. Because of this, physicians need to manage complications that are influencing the patients’ quality of life and survival.

One of these side effects is pleural effusions: a buildup of fluid between the layers of tissue that line the lungs and chest cavity. Khuri and colleagues found that although there were no definitive answers as to the best way to treat pleural effusions, if physicians treat the patient early, survival is extended with fewer complications.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
2 experts are featured in this series.
2 experts are featured in this series.
Photo of a woman with brown hair and a floral blouse
Photo of a woman with a blue border around the image
2 experts are featured in this series.
2 experts are featured in this series.
Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
Image of a woman with white hair in front of an Oncology Nursing News blue background